Nov 07, 2019 / 04:00AM GMT
Presentation
Nov 07, 2019 / 04:00AM GMT
=====================
Corporate Participants
=====================
* Kazuo Koshiji
Santen Pharmaceutical Co., Ltd. - Senior Corp. Officer of Corporate Administration, CFO and Head of Finance & Administration Division
* Naveed Shams
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Chief Scientific Officer and Head of Global Research & Development
* Satoshi Suzuki
Santen Pharmaceutical Co., Ltd. - Senior Corporate Officer, Head of Corporate Development Division & Head of China Business
* Shigeo Taniuchi
Santen Pharmaceutical Co., Ltd. - President, COO, Head of North America Business & Director
=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group Inc., Research Division - Equity Analyst
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Motoya
Santen Pharmaceutical Co Ltd
(OTCPK:SNPHY)
$
12.24
+0.47 (+3.99%)
Market Cap: 3.94 Bil
Enterprise Value: 3.40 Bil
PE Ratio: 16.50
PB Ratio: 2.18
GF Score: 79/100 Q2 2020 Santen Pharmaceutical Co Ltd Earnings Presentation Transcript
Nov 07, 2019 / 04:00AM GMT
Release Date Price:
$18.35
(+1.94%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers